TIMM10 (translocase of inner mitochondrial membrane 10) is a mitochondrial intermembrane chaperone that facilitates the import and insertion of multi-pass transmembrane proteins into the mitochondrial inner membrane. It functions as a chaperone-like protein protecting hydrophobic precursors from aggregation and guiding them through the intermembrane space, potentially participating in transfer of β-barrel precursors from the TOM to SAM complex. Clinically, TIMM10 dysregulation is associated with multiple disease states. In heart failure from both ischemic and dilated cardiomyopathy, TIMM10 expression is significantly downregulated alongside other mitochondrial quality control genes, indicating impaired mitochondrial protein import capacity 1. TIMM10 has been identified as a component of prognostic biomarker signatures in prostate cancer 2 and tuberculosis progression 3, though with limited predictive performance for TB progression specifically. TIMM10 exhibits significant sex-dependent expression differences and may influence COVID-19 severity variability 4. Additionally, TIMM10 expression changes occur during sperm capacitation through ubiquitin-proteasome system regulation 5, and it appears in molecular signatures distinguishing tuberculosis from healthy controls 6. TIMM10 was also identified among genes associated with myelodysplastic syndrome evolution to acute leukemia 7.